Ming-Ru Wu, Ph.D.
Affiliations: | 2015 | Immunology and Microbiology | Dartmouth College, Hanover, NH, United States |
Area:
ImmunologyGoogle:
"Ming-Ru Wu"Parents
Sign in to add mentor| Charles L. Sentman | grad student | 2015 | Dartmouth | |
| (Harnessing natural killer cell receptors for tumor immunotherapy.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Wang Y, Buck A, Piel B, et al. (2024) Affinity fine-tuning anti-CAIX CAR-T cells mitigate on-target off-tumor side effects. Molecular Cancer. 23: 56 |
| Suh J, Kim H, Min J, et al. (2023) Decoupling NAD metabolic dependency in chondrosarcoma by targeting the SIRT1-HIF-2α axis. Cell Reports. Medicine. 101342 |
| Wu MR, Nissim L, Stupp D, et al. (2019) A high-throughput screening and computation platform for identifying synthetic promoters with enhanced cell-state specificity (SPECS). Nature Communications. 10: 2880 |
| Wu MR, Jusiak B, Lu TK. (2019) Engineering advanced cancer therapies with synthetic biology. Nature Reviews. Cancer |
| Nissim L, Wu MR, Pery E, et al. (2017) Synthetic RNA-Based Immunomodulatory Gene Circuits for Cancer Immunotherapy. Cell |
| Lee G, Atia L, Lan B, et al. (2017) Contact guidance and collective migration in the advancing epithelial monolayer. Connective Tissue Research |
| Sentman ML, Murad JM, Cook WJ, et al. (2016) Mechanisms of Acute Toxicity in NKG2D Chimeric Antigen Receptor T Cell-Treated Mice. Journal of Immunology (Baltimore, Md. : 1950) |
| Wu MR, Zhang T, Gacerez AT, et al. (2015) B7H6-Specific Bispecific T Cell Engagers Lead to Tumor Elimination and Host Antitumor Immunity. Journal of Immunology (Baltimore, Md. : 1950). 194: 5305-11 |
| Wu MR, Zhang T, DeMars LR, et al. (2015) B7H6-specific chimeric antigen receptors lead to tumor elimination and host antitumor immunity. Gene Therapy |
| Wu MR, Zhang T, Alcon A, et al. (2015) DNAM-1-based chimeric antigen receptors enhance T cell effector function and exhibit in vivo efficacy against melanoma. Cancer Immunology, Immunotherapy : Cii. 64: 409-18 |